| Q39203842 | Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation. |
| Q88802576 | Evaluation of melatonin and AFMK levels in women with breast cancer |
| Q39208543 | Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma |
| Q42754608 | Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection. |
| Q94561719 | Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus |
| Q28607080 | LINE-1 activity as molecular basis for genomic instability associated with light exposure at night |
| Q39578184 | Light and the City: Breast Cancer Risk Factors Differ Between Urban and Rural Women in Israel |
| Q37200722 | Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression. |
| Q48411570 | Melatonin has differential effects on age-induced stoichiometric changes in daily chronomics of serotonin metabolism in SCN of male Wistar rats |
| Q35784330 | Melatonin membrane receptors in peripheral tissues: distribution and functions |
| Q39404369 | Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells |
| Q34246413 | Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts |
| Q38002452 | Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation |
| Q36913537 | Melatonin-based therapeutics for neuroprotection in stroke |
| Q38046127 | Molecular mechanisms of melatonin's inhibitory actions on breast cancers. |
| Q38973727 | The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis |
| Q28087454 | The aging clock and circadian control of metabolism and genome stability |
| Q89505525 | The role of melatonin on miRNAs modulation in triple-negative breast cancer cells |
| Q29248164 | URINARY MELATONIN IN RELATION TO POSTMENOPAUSAL BREAST CANCER RISK ACCORDING TO MELATONIN 1 RECEPTOR STATUS |